The PE Ratio as of June 2026 (TTM) for Alto Neuroscience, Inc. (ANRO) is -8.84

According to Alto Neuroscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.84. This represents a change of 90.25% compared to the average of -4.65 of the last 4 quarters.

Alto Neuroscience, Inc. (ANRO) Historical PE Ratio (quarterly & annually)

How has ANRO PE Ratio performed in the past?

The mean historical PE Ratio of Alto Neuroscience, Inc. over the last ten years is -20.37. The current -8.84 PE Ratio has changed 4.24% with respect to the historical average. Over the past ten years (40 quarters), ANRO's PE Ratio was at its highest in in the June 2025 quarter at -0.84. The PE Ratio was at its lowest in in the March 2023 quarter at -19.10.

Alto Neuroscience, Inc. (ANRO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alto Neuroscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alto Neuroscience, Inc. (ANRO) Average PE Ratio

How has ANRO PE Ratio performed in the past?

The current PE Ratio of Alto Neuroscience, Inc. (ANRO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alto Neuroscience, Inc. (ANRO) PE Ratio vs. Peers

How is ANRO’s PE Ratio compared to its peers?

Alto Neuroscience, Inc.’s PE Ratio is less than Cellectis S.A. (-4.79), less than AC Immune S.A. (-2.74), greater than Amarin Corporation plc (-9.43), less than Larimar Therapeutics, Inc. (-1.78), less than Contineum Therapeutics, Inc. Class A Common Stock (-7.59), less than Aldeyra Therapeutics, Inc. (-3.88), greater than Alpha Tau Medical Ltd. (-15.54), less than Silence Therapeutics plc (-3.71), less than Korro Bio, Inc. (-1.19), greater than DBV Technologies S.A. (-8.91),

Build a custom stock screener for Alto Neuroscience, Inc. (ANRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alto Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alto Neuroscience, Inc. (ANRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alto Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.